FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileAlcon Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
ALC
Alcon Inc. Stock AnalysisComprehensive stock analysis for Alcon Inc. (ALC) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisALC
ALC
Alcon Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
ALC
  1. Home
  2. Stocks
  3. Alcon Inc.

Alcon Inc.

🇺🇸ALC•NYSE

Alcon Inc.

🇺🇸ALC•NYSE
Market cap
$35.70B
P/E ratio
54.83

Your view on ALC

Mkt Cap
$35.70B
P/E
54.83
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Alcon Inc.

Industry
Medical - Specialties
Sector
Healthcare
CEO
David J. Endicott
Headquarters
Chemin de Blandonnet 8, Geneva, CH
Industry
Medical - Specialties
Sector
Healthcare
CEO
David J. Endicott
Headquarters
Chemin de Blandonnet 8, Geneva, CH
Description

Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide.

The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures.

Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under the PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery.

Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands.

The company was formerly known as Alcon Universal S.A. and changed the name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Financial Data

Stock Data

Price chart, volume, and trading data.

What moved it

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Alcon Inc. from FRC's valuation model, read against the market price. ALC last traded at $74.31, 54.8× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Alcon Inc.. Starting points for Alcon Inc.: P/E 54.8, EPS $1.38, beta 0.72 — an Medical - Specialties name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Alcon Inc.. Alcon Inc. paid $0.36 per share over the last year — a 0.5% yield at the current $74.31 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Alcon Inc.. Trailing twelve-month EPS for Alcon Inc. stands at $1.38. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 22, 2026
Analysts' target$79.24average of 12 firms, last 12 months
Current price—

Buy

Targets, low to high

$79.24

Low $35.00

Middle $84.50

High $98.00

Analyst ratings

11 firms, last 12 months
  • Strong Buy0
  • Buy7
  • Hold3
  • Sell1
  • Strong Sell0
More →

Earnings per share estimates

Per shareThis quarterDec 2026Next quarterMar 2027This yearYear to Dec 2026Next yearYear to Dec 2027
Average estimate$0.88$0.92$3.43$3.81
Lowest estimate$0.85$0.88$3.42$3.66
Highest estimate$0.93$1.05$3.46$3.95
Number of analysts831516
A year ago$0.78$0.85$1.98—
Growth vs a year ago+13.3%+8.6%+73.5%—

Revenue estimates

TotalThis quarterDec 2026Next quarterMar 2027This yearYear to Dec 2026Next yearYear to Dec 2027
Average estimate$2.79B$2.78B$10.89B$11.49B
Lowest estimate$2.78B$2.68B$10.86B$11.44B
Highest estimate$2.80B$3.06B$10.97B$11.54B
Number of analysts421417
A year ago$2.72B$2.65B$10.40B—
Growth vs a year ago+2.8%+4.6%+4.7%—
Recent rating and target changes (15)

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Alcon Inc.. Alcon Inc. has reported as a listed company since 2019. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold ALC20 companies · 8 funds
Compare ALC with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustryMkt cap
BLCOBausch + Lomb CorporationHealthcareMedical - Instruments & Supplies$6.9B
COOThe Cooper Companies, Inc.HealthcareMedical - Instruments & Supplies$11.2B
ESLOYEssilorLuxottica S.A.HealthcareMedical - Instruments & Supplies$129.8B
GKOSGlaukos CorporationHealthcareMedical - Devices$14.0B
HOCPFHOYA CorporationHealthcareMedical - Instruments & Supplies$64.6B
IRIXIRIDEX CorporationHealthcareMedical - Devices$7.9M
LNSRLENSAR, Inc.HealthcareMedical - Devices$54.8M
RXSTRxSight, Inc.HealthcareMedical - Devices$187.4M
More Medical - Specialties companies
TickerTypeCompanySectorExchangeMkt cap
UAHCUnited American Healthcare CorporationHealthcareOTC$1.1M
UEECUnited Health Products, Inc.HealthcareOTC$14.9M
VFY.AXVitrafy Life Sciences Ltd.HealthcareASX—
VMTHFVenus Medtech (Hangzhou) Inc.HealthcareOTC$184.7M
VVVVvVARDIS HOLDING AG Class AHealthcareNYSE$558.7M
WCUIWellness Center USA, Inc.HealthcareOTC$13,063
WOKWORK Medical Technology Group Ltd.HealthcareNASDAQ$4.8M
YPHDFYpsomed Holding AGHealthcareOTC$5.2B
ACAISafeplus International Holdings LimitedHealthcareOTC$477
ADLIAmerican Medical Technologies Inc.HealthcareOTC$1,031
AIMVAI Maverick Intel, Inc.HealthcareOTC$3.0M
ANIKAnika Therapeutics, Inc.HealthcareNASDAQ$177.2M
ETFs holding Alcon Inc.
TickerFundFund assets% of the fund
EQTYKovitz Core Equity ETF$1.4B in assets3.06%
DFIVDimensional - International Value ETF$22.0B in assets0.17%
DFAIDimensional - International Core Equity Market ETF$17.9B in assets0.12%
DFICDimensional - International Core Equity 2 ETF$15.4B in assets0.10%
YLDWWestwood Enhanced Income Opport$43M in assets1.31%
HRTSTema Cardiovascular and Metabolic ETF$58M in assets1.06%
IMFLInvesco International Developed Dynamic Multifactor ETF$1.1B in assets0.19%
QDX.TOMackenzie International Equity Index ETF$2.1B in assets0.17%

Largest holders first, then the funds most concentrated in ALC.

Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Alcon Inc., and how their positions are changing. At a $35.70B market value, institutional positions materially move Alcon Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

About this section

U.S. Senate disclosures naming Alcon Inc.. Alcon Inc. is a $35.70B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

About this section

U.S. House of Representatives disclosures naming Alcon Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Alcon Inc.. Coverage tracks Alcon Inc. within Medical - Specialties (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Alcon Inc.

ALC AnalysisFair
Past
1
Growth
3
Health
4
Profit
1
Value
1